Trade SLXN anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Silexion Therapeutics Corp (SLXN) is trading at US$0.37, up 2.44% today as of Aug 28, 12:00 EDT. The company has a market capitalisation of US$2.19M. Over the past 52 weeks, SLXN has traded between US$0.35 and US$80.00. On Syfe you can trade SLXN with $0 commission and add it to your watchlist.
| Previous close | US$0.36 |
|---|---|
| Market cap | US$2.19M |
| 52-week range | US$0.35 – US$80.00 |
| Volume | 272.82K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Silexion Therapeutics Corp
Silexion Therapeutics Corp. is a clinical-stage biotechnology company, which engages in the discovery and development of treatments for KRAS-driven cancers. The company was founded on November 30, 2008 and is headquartered in in Modiin, Israel.
Year: 2024
Silexion Therapeutics Initiates Phase 2/3 Trial for Pancreatic Cancer Drug Candidate
Jul 29, 1:43 PM · MT Newswires
Silexion Therapeutics Says Germany Approves Phase 2/3 Trial of SIL204 in Pancreatic Cancer
Jun 23, 1:31 PM · MT Newswires
Silexion Therapeutics Corp (SLXN) stock is trading at US$0.37, +2.44% from the previous close of US$0.36.
The market cap for Silexion Therapeutics Corp (SLXN) stock is approximately US$2.19M.
The 52-week high for Silexion Therapeutics Corp (SLXN) stock is US$80.00.
The 52-week low for Silexion Therapeutics Corp (SLXN) stock is US$0.35.
Silexion Therapeutics Corp (SLXN) does not currently pay a dividend.
Stay on top of SLXN
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
